Table 3 Summary results of the genetic covariance analyses between neuropsychiatric disorders and somatic diseases linked with insulin-resistance stratified by insulin signalling gene sets.
Gene-set name | n genes/gene set | Base phenotypes | ρg | SE ρg | p | h2SNP (1) | h2SNP (2) | Annotated SNPs | Total SNPs |
---|---|---|---|---|---|---|---|---|---|
Biocarta insulin pathway | 21 | AN × T2DM | −0.00042a | 0.00010 | 1.26 × 10−5 b | 0.00078 | 0.00050 | 1268 | 860,288 |
Biocarta insulin pathway | 21 | ASD × MetS | −0.00041 | 0.00010 | 1.96 × 10−5 | 0.00046 | 0.00068 | 1520 | 968,964 |
KEGG insulin signaling pathway | 137 | ASD × MetS | −0.00170 | 0.00041 | 3.22 × 10−5 | 0.00261 | 0.00207 | 11,334 | 968,964 |
PID insulin pathway | 44 | ASD × MetS | −0.00080 | 0.00018 | 1.25 × 10−5 | 0.00012 | 0.00105 | 4319 | 968,964 |
PID insulin pathway | 44 | BD × T2DM | −0.00057a | 0.00013 | 9.60 × 10−6 b | 0.00054 | 0.00121 | 4575 | 1,026,853 |
PID insulin pathway | 44 | BD × MetS | −0.00076a | 0.00018 | 2.03 × 10−5 b | 0.00054 | 0.00109 | 4580 | 1,027,553 |
PID insulin pathway | 44 | SCZ × MetS | −0.00141 | 0.00032 | 1.32 × 10−5 | 0.00155 | 0.00117 | 4836 | 1,049,783 |
Reactome insulin processing | 27 | AN × T2DM | 0.00059a | 0.00014 | 3.77 × 10−5 b | 0.00216 | 0.00153 | 2742 | 860,288 |
Reactome regulation of insulin secretion | 77 | ADHD × MetS | 0.00174 | 0.00045 | 1.18 × 10−4 | 0.00287 | 0.00156 | 9850 | 986,120 |
Reactome insulin receptor recycling | 26 | AD × Obesity | −0.00079a | 0.00019 | 4.61 × 10−5 b | 0.00009 | −0.00033 | 2138 | 942,664 |
Reactome insulin receptor recycling | 26 | OCD × MetS | −0.00124 | 0.00028 | 7.5 × 10−6 | 0.00316 | 0.00074 | 2132 | 1,019,413 |
Reactome insulin receptor recycling | 26 | OCD × T2DM | −0.00100 | 0.00026 | 1.6 × 10−4 | 0.00304 | 0.00128 | 2130 | 1,019,648 |